Comparison of Adalimumab and Steroid in Intestinal Behcet's disease
Comparison of Adalimumab and Steroid in Intestinal Behcet's disease - Castle Study
Intestinal Behcet's disease
Subcutaneous injection of adalumumab with 160mg at 0 week, 80mg at 2 weeks and 40mg every other week after at 4 weeks continuously. Oral administration of prednisolone with 0.6mg/kg/day during from 1 to 2 weeks, and tapering off until 12 weeks with decreasing dosage 5mg/kg/week approximately Subcutaneous injection of adalumumab with 160mg at 0 week, 80mg at 2 weeks and 40mg every other week ...